Repurposing Renin–Angiotensin System Drugs for the Treatment of Audiovestibular Disorders
Open Access
- 16 January 2026
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 743
Abstract
Audiovestibular disorders arising from the inner ear (e.g., hearing loss, tinnitus, vertigo) are widely prevalent in the United States. Yet, medical treatments targeting the underlying pathology of these disorders remain scarce. The practice of repurposing FDA-approved drugs for new therapeutic indications has become increasingly common, offering a lower risk route to treatment development with fewer barriers to implementation, as safety profiles are already established. The renin–angiotensin system (RAS) is well known for its role in blood pressure and fluid balance, and its overactivation induces acute and chronic inflammation and oxidative stress. This review discusses existing evidence and proposed otoprotective mechanisms of RAS inhibition, specifically using angiotensin II type 1 receptor blockers (ARBs), which support the repurposing of these medications as novel treatments to affect the inner ear pathologies that underlay hearing loss, tinnitus, and vertigo.Keywords
Funding Information
- Univ of Iowa Department of Otolaryngology (Schilling Resident Research Grant)
This publication has 177 references indexed in Scilit:
- Effect of Self-treatment of Recurrent Benign Paroxysmal Positional VertigoJAMA Neurology, 2023
- Lifestyle and dietary interventions for Ménière’s diseaseCochrane Database of Systematic Reviews, 2023
- Treatment of HypertensionJAMA, 2022
- Sound therapy (using amplification devices and/or sound generators) for tinnitusCochrane Database of Systematic Reviews, 2018
- Effectiveness of Guided Internet-Based Cognitive Behavioral Therapy vs Face-to-Face Clinical Care for Treatment of TinnitusJAMA Otolaryngology–Head & Neck Surgery, 2018
- Corticosteroids and Vestibular Exercises in Vestibular NeuritisJAMA Otolaryngology–Head & Neck Surgery, 2014
- Amplification with hearing aids for patients with tinnitus and co-existing hearing lossCochrane Database of Systematic Reviews, 2014
- Steroids for idiopathic sudden sensorineural hearing lossCochrane Database of Systematic Reviews, 2013
- Repetitive transcranial magnetic stimulation for tinnitusCochrane Database of Systematic Reviews, 2011
- Exposure to hazardous workplace noise and use of hearing protection devices among US workers—NHANES, 1999–2004American Journal of Industrial Medicine, 2009